IRONWOOD PHARMA
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IRONWOOD PHARMA NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV, CUSIP 46333XAC2.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IRONWOOD PHARMA NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV, CUSIP 46333XAC2.